Bellicum Pharmaceuticals Inc.

02/26/2024 | Press release | Distributed by Public on 02/27/2024 05:08

Notice of Effectiveness - Form EFFECT

Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 26, 2024
Accession Number: 0001539497-24-000584
Submission Type: POS AM
CIK: 0001358403
Company Name: BELLICUM PHARMACEUTICALS, INC
File Number: 333-232771